Unique ID issued by UMIN | UMIN000003700 |
---|---|
Receipt number | R000004482 |
Scientific Title | Evaluation of the usefulness and safety of goserelin plus tamoxifen as neoadjuvant hormone therapy for premenopausal patients with hormone receptor-positive breast cancer |
Date of disclosure of the study information | 2010/06/03 |
Last modified on | 2018/08/03 11:05:38 |
Evaluation of the usefulness and safety of goserelin plus tamoxifen as neoadjuvant hormone therapy for premenopausal patients with hormone receptor-positive breast cancer
Evaluation of the usefulness and safety of goserelin plus tamoxifen as neoadjuvant hormone therapy for premenopausal patients with hormone receptor-positive breast cancer
Evaluation of the usefulness and safety of goserelin plus tamoxifen as neoadjuvant hormone therapy for premenopausal patients with hormone receptor-positive breast cancer
Evaluation of the usefulness and safety of goserelin plus tamoxifen as neoadjuvant hormone therapy for premenopausal patients with hormone receptor-positive breast cancer
Japan |
Breast cancer
Hematology and clinical oncology | Breast surgery |
Malignancy
NO
The efficacy and safety will be evaluated that goserelin plus tamoxifen is administered to premenopausal patients with hormone receptor-positive invasive breast cancer. The utility of measuring Ki67 for time will be evaluated.
Safety,Efficacy
Exploratory
Pragmatic
Phase II
Clinical response
Pathological response
Safety
Clinical usefulness
Changing of Ki67-score
Disease Free Survival
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Neoadjuvant endocrine therapy (goserelin + tamoxifen)
Not applicable |
Not applicable |
Female
Premenopausal women with invasive breast cancer who meet the following inclusion criteria.
(1) Clinical Stage I-IIB: T1-3N0M0
(2) Patients with a definite diagnosis of invasive breast cancer by core needle biopsy.
(3) Patients who meet one of the following criteria for premenopause.
(i) Periodic menstruation bleeding.
(ii) Patients with amenorrhea in whom LH or FSH is <30 IU/mL and E2 is >10 pg/mL.
(4) Patients who has ER positive tumors (Allred total score (TS) is 3 or moreover) in immunohistochemical staining. Not concerned with PgR.
(5) HER2 negative by IHC or FISH
(6) Patients with bone marrow, renal, and hepatic functions which are adequate to evaluate the safety of the study drug accurately.
WBC: >3,000/mm3
Hemoglobin: >9.0 g/dL
Platelet count: >10.0 x10000/mm3
AST/ALT: <1.5times the upper limit of the normal range for the medical institution.
Serum creatinine: <1.25 times the upper limit of the normal range for the medical institution.
(7) ECOG PS is 0-2.
(8) Patients who can provide biopsy tissue specimens, isolated tissues, and blood samples
(1) Patients with previous treatment for the breast cancer.
(2) Patients receiving drugs having a potential influence on the status of sex hormones (hormone replacement therapy, raloxifene, etc.). (However, patients after washout for at least 2 months can be enrolled.)
(3) Patients with myocardial infarction or congestive heart failure at the past history, or patients who need treatment of ischemic hear disease, arryhythmia or valvular disorder.
(4) Patients with active double cancer.
(5) Inflammatory breast cancer
(6) Synchronous or asynchrous bilateral breast cancer.
(7) Allergy for radio-enhancer
(8) New test drug
(9) Severe psychosomatic disease
(10) Patients whom doctors judged inadequate to the enrollment of this study by other reasons.
55
1st name | |
Middle name | |
Last name | Koichiro Tsugawa, M.D. |
St. Luke's International Hospital
Department of Breast Surgical Onocology
9-1, Akashi-cho, Chuo-ku, Tokyo
03-3541-5151
1st name | |
Middle name | |
Last name | Koichiro Tsugawa, M.D. |
St. Luke's International Hospital
Department of Breast Surgical Onocology
9-1, Akashi-cho, Chuo-ku, Tokyo
03-3541-5151
koitsuga@luke.or.jp
St. Luke's International Hospital
None
Self funding
NO
2010 | Year | 06 | Month | 03 | Day |
Unpublished
Terminated
2010 | Year | 03 | Month | 15 | Day |
2010 | Year | 06 | Month | 01 | Day |
2010 | Year | 06 | Month | 03 | Day |
2018 | Year | 08 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004482
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |